Does LAZERTINIB Cause Dyspnoea? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Dyspnoea have been filed in association with LAZERTINIB (LAZCLUZE). This represents 3.1% of all adverse event reports for LAZERTINIB.
11
Reports of Dyspnoea with LAZERTINIB
3.1%
of all LAZERTINIB reports
1
Deaths
2
Hospitalizations
How Dangerous Is Dyspnoea From LAZERTINIB?
Of the 11 reports, 1 (9.1%) resulted in death, 2 (18.2%) required hospitalization, and 1 (9.1%) were considered life-threatening.
Is Dyspnoea Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LAZERTINIB. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does LAZERTINIB Cause?
Rash (77)
Neuropathy peripheral (32)
Infusion related reaction (30)
Fatigue (26)
Diarrhoea (20)
Off label use (19)
Paronychia (16)
Pruritus (13)
Nausea (12)
Oedema peripheral (11)
What Other Drugs Cause Dyspnoea?
ALBUTEROL (21,856)
TREPROSTINIL (16,348)
AMBRISENTAN (13,367)
PREDNISONE (12,830)
BUDESONIDE\FORMOTEROL (11,158)
TIOTROPIUM (10,863)
ADALIMUMAB (10,547)
DUPILUMAB (10,310)
FLUTICASONE\SALMETEROL (9,783)
MEPOLIZUMAB (9,192)
Which LAZERTINIB Alternatives Have Lower Dyspnoea Risk?
LAZERTINIB vs LEBRIKIZUMAB-LBKZ
LAZERTINIB vs LECANEMAB
LAZERTINIB vs LECANEMAB-IRMB
LAZERTINIB vs LECITHIN\POLOXAMER 407
LAZERTINIB vs LEDIPASVIR